文献速递炎症性肠病

炎症性肠病女性妊娠结局:十年全国人群队列研究

Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort study.
PubMed 文献 · Aliment Pharmacol Ther · 2020-04-07

结果显示IBD女性妊娠率低于无IBD女性(25.7% vs 32.3%,P<0.001);克罗恩病患者剖宫产和宫内生长迟缓风险增加;中重度IBD患者活产率降低,自然流产、剖宫产和宫内生长迟缓风险显著增加,而静止期至轻度IBD患者妊娠结局与对照组无显著差异。

要点

  • IBD女性妊娠率低于无IBD女性(25.7% vs 32.3%,P<0.001)。
  • 克罗恩病患者剖宫产和宫内生长迟缓风险高于对照。
  • 中重度IBD与活产率降低、自然流产、剖宫产和IUGR风险增加相关。

核心结论

  • 除中重度疾病外,IBD女性不良妊娠结局的发生率与一般人群相似。

主要发现

  • IBD女性妊娠率低于无IBD女性(25.7% vs 32.3%,P<0.001)。
  • 克罗恩病患者剖宫产率(46.5% vs 38.8%,OR 1.43,95%CI 1.17-1.75)和宫内生长迟缓率(3.0% vs 1.0%,OR 2.89,95%CI 1.59-5.26)高于对照。
  • 中重度IBD患者活产率低于对照(65.0% vs 69.9%,OR 0.79,95%CI 0.66-0.94)。
  • 中重度IBD与自然流产(14.9% vs 11.9%,OR 1.33,95%CI 1.04-1.68)、剖宫产(46.4% vs 38.8%,OR 1.41,95%CI 1.14-1.74)和宫内生长迟缓(3.4% vs 1.0%,OR 3.20,95%CI 1.75-5.84)风险增加相关。
  • 静止期至轻度IBD患者与对照的妊娠结局无显著差异。

临床怎么用

  • 对IBD女性应评估疾病活动度,中重度患者妊娠不良结局风险较高,需加强管理。
  • 克罗恩病患者妊娠期间应关注剖宫产和宫内生长迟缓风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data relating to the association between inflammatory bowel disease (IBD) and pregnancy outcomes are lacking in Korea. AIMS: To determine the incidence rates of pregnancy outcomes in women with IBD. METHODS: A nationwide population study was performed using the Korean National Health Insurance claims database. A total of 2058 women with IBD consisting of ulcerative colitis (UC, n = 1469) and Crohn's disease (CD, n = 589) were pregnant between 2007 and 2016. We compared their incidence of pregnancy outcomes with 20 580 age-matched controls without IBD. We also stratified the patients into those with quiescent to mild and moderate to severe IBD and compared the outcomes between them. RESULTS: The pregnancy rate of women with IBD was lower than that of women without (25.7% vs 32.3%, P < 0.001). Caesarean section (46.5% vs 38.8%, odds ratio [OR] 1.43, 95% confidence interval [CI]: 1.17-1.75), and intrauterine growth retardation (IUGR) (3.0% vs 1.0%, OR 2.89, 95% CI: 1.59-5.26) were increased in CD patients than the controls. In regards to disease severity, there were no significant differences in pregnancy outcomes between patients with quiescent to mild IBD and the controls. However, the live birth rate of patients with moderate to severe IBD was lower than that of the controls (65.0% vs 69.9%, OR 0.79, 95%CI: 0.66-0.94). In addition, moderate to severe IBD was significantly associated with spontaneous abortion (14.9% vs 11.9%, OR 1.33, 95% CI: 1.04-1.68), caesarean section (46.4% vs 38.8%, OR 1.41, 95% CI: 1.14-1.74) and IUGR (3.4% vs 1.0%, OR 3.20, 95% CI: 1.75-5.84). CONCLUSIONS: With the exception of moderate to severe disease, the incidences of adverse pregnancy outcomes in women with IBD are similar to that of the general population.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Lee HH, Bae JM, Lee BI, et al. Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort study. Aliment Pharmacol Ther. 2020. PMID: 32266739. doi:10.1111/apt.15654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。